A detailed history of Andra Ap Fonden transactions in United Therapeutics Corp stock. As of the latest transaction made, Andra Ap Fonden holds 61,100 shares of UTHR stock, worth $22.3 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
61,100
Previous 35,100 74.07%
Holding current value
$22.3 Million
Previous $11.2 Million 95.82%
% of portfolio
0.33%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $8.09 Million - $9.45 Million
26,000 Added 74.07%
61,100 $21.9 Million
Q2 2024

Aug 07, 2024

BUY
$228.26 - $319.04 $433,694 - $606,176
1,900 Added 5.72%
35,100 $11.2 Million
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $484,748 - $573,873
-2,300 Reduced 6.48%
33,200 $7.63 Million
Q4 2023

Feb 15, 2024

BUY
$214.88 - $256.94 $236,368 - $282,634
1,100 Added 3.2%
35,500 $7.81 Million
Q3 2023

Nov 09, 2023

SELL
$211.82 - $248.24 $190,638 - $223,416
-900 Reduced 2.55%
34,400 $7.77 Million
Q2 2023

Aug 09, 2023

BUY
$205.19 - $232.99 $7.24 Million - $8.22 Million
35,300 New
35,300 $7.79 Million
Q2 2019

Aug 15, 2019

SELL
$76.06 - $120.81 $4.11 Million - $6.54 Million
-54,100 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$107.15 - $126.84 $1.56 Million - $1.85 Million
-14,600 Reduced 21.25%
54,100 $6.35 Million
Q3 2018

Oct 16, 2018

SELL
$113.81 - $129.46 $910,480 - $1.04 Million
-8,000 Reduced 10.43%
68,700 $8.79 Million
Q2 2018

Aug 17, 2018

BUY
$101.14 - $118.31 $596,726 - $698,029
5,900 Added 8.33%
76,700 $8.68 Million
Q1 2018

Apr 10, 2018

BUY
$107.21 - $151.94 $6.24 Million - $8.84 Million
58,200 Added 461.9%
70,800 $7.96 Million
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $367,598 - $468,968
-3,100 Reduced 19.75%
12,600 $1.86 Million
Q3 2017

Oct 31, 2017

BUY
$114.6 - $136.81 $1.8 Million - $2.15 Million
15,700
15,700 $1.84 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.